Skip to main content
. 2022 Jun 3;9:875021. doi: 10.3389/fcvm.2022.875021

Table 1.

Baseline demographics, clinical characteristics, and thrombolysis contraindications of all treated patients.

Variable No. (%)
Age, years, mean (range) 54.7 (27–72)
Sex
   Male 7 (77.8)
   Female 2 (22.2)
Symptoms
   Dyspnea 9 (100)
   Chest pain 9 (100)
   Presyncope or syncope 8 (88.9)
Clinical findings at presentation
   Hypoxia 9 (100)
   Hypotension 8 (88.9)
   Right ventricular dysfunction 9 (100)
Troponin I > 0.01 ng/mL 5 (55.6)
Echocardiography
   Right ventricular dilationa 5 (55.6)
   Abnormal interventricular septal motion 5 (55.6)
Computed tomography angiography
   Main branch embolus 9 (100.0)
   Massive pulmonary embolus 5 (55.6)
   Submassive pulmonary embolus 4 (44.4)
Contraindications to thrombolysis
   Recent major surgery 4 (44.4)
   Recent trauma with shock 3 (33.3)
   Malignant tumor 1 (11.1)
   Active bleeding 1 (11.1)
   Recent stroke (<14 days) 1 (11.1)
Comorbidities
   Hypertension 2 (22.2)
   Diabetes 1 (11.1)
   Coronary artery disease 1 (11.1)
a

Right ventricular/left ventricular diameter ratio >1.40.